Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4776151
Max Phase: Preclinical
Molecular Formula: C25H28N6O
Molecular Weight: 428.54
Molecule Type: Unknown
Associated Items:
ID: ALA4776151
Max Phase: Preclinical
Molecular Formula: C25H28N6O
Molecular Weight: 428.54
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1cc([C@H](CCN[C@@H]2CC[C@@H](c3ccccc3)OC2)c2ccccc2)c2nn[nH]c2n1
Standard InChI: InChI=1S/C25H28N6O/c26-23-15-21(24-25(28-23)30-31-29-24)20(17-7-3-1-4-8-17)13-14-27-19-11-12-22(32-16-19)18-9-5-2-6-10-18/h1-10,15,19-20,22,27H,11-14,16H2,(H3,26,28,29,30,31)/t19-,20-,22+/m1/s1
Standard InChI Key: WBQKPMCSWFRWPE-SJBKTWHCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 428.54 | Molecular Weight (Monoisotopic): 428.2325 | AlogP: 3.97 | #Rotatable Bonds: 7 |
Polar Surface Area: 101.74 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.30 | CX Basic pKa: 9.79 | CX LogP: 2.75 | CX LogD: 1.94 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.41 | Np Likeness Score: -0.14 |
1. Shaw SA,Vokits BP,Dilger AK,Viet A,Clark CG,Abell LM,Locke GA,Duke G,Kopcho LM,Dongre A,Gao J,Krishnakumar A,Jusuf S,Khan J,Spronk SA,Basso MD,Zhao L,Cantor GH,Onorato JM,Wexler RR,Duclos F,Kick EK. (2020) Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase., 28 (22): [PMID:33007547] [10.1016/j.bmc.2020.115723] |
Source(1):